Seroprevalence studies of pertussis: what have we learned from different immunized populations (Q38553680)

4 September 2017

1 reference

title

Seroprevalence studies of pertussis: what have we learned from different immunized populations (English)

1 reference

Kirsi Gröndahl-Yli-Hannuksela

4 September 2017

0 references

0 references

series ordinal

2

object named as

Kirsi Gröndahl-Yli-Hannuksela

1 reference

4 September 2017

Alex-Mikael Barkoff

1

1 reference

PubMed ID

26208655

4 September 2017

Qiushui He

series ordinal

3

1 reference

4 September 2017

24 July 2015

1 reference

4 September 2017

Pathogens and disease

1 reference

4 September 2017

73

1 reference

4 September 2017

7

1 reference

Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway

4 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Molecular epidemiology of the pertussis epidemic in Washington State in 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Bordetella pertussis, Finland and France

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Pertussis re-emergence in the post-vaccination era

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalence of Bordetella pertussis in the Mexican population: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Severe and unrecognised: pertussis in UK infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Bordetella pertussis vaccine strains and circulating isolates in Serbia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalence of pertussis among Danish patients with cough of unknown etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Recent findings on pertussis epidemiology in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

The seroepidemiology of B. pertussis infection in Catalonia, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Pertussis before and after the introduction of acellular pertussis vaccines in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalance of pertussis antibodies in maternal and cord blood of preterm and term infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Strategies to decrease pertussis transmission to infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalence of pertussis in Senegal: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Pertussis: a review of disease epidemiology worldwide and in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Sensitivity and specificity of the World Health Organization pertussis clinical case definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

21 January 2018

How to fight pertussis?

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Microbiological and serological diagnosis of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalence of Immunoglobulin G antibodies against pertussis toxin among asymptomatic medical students in the west of Iran: a cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

The epidemiology of pertussis in Germany: past and present

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Clinical practice. Pertussis--not just for kids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Bordetella pertussis seroprevalence in Belgian adults aged 20-39 years, 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Comparison of commercially available immunoblot assays measuring IgG and IgA antibodies to Bordetella pertussis antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Waning protection after fifth dose of acellular pertussis vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Distribution of pertussis antibodies among different age groups in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Pertussis seroprevalence in korean adolescents and adults using anti-pertussis toxin immunoglobulin G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Duration of pertussis immunity after DTaP immunization: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

The utility of seroepidemiology for tracking trends in pertussis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

The seroepidemiology of pertussis in NSW: fluctuating immunity profiles related to changes in vaccination schedules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Coverage and timing of children's vaccination: an evaluation of the expanded programme on immunisation in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Pertussis antibodies in postpartum women and their newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Pertussis Epidemiology in Greece and Emerging Risk Groups during the Vaccination Era (1980-2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Acellular pertussis vaccines in Japan: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Duration of immunity against pertussis after natural infection or vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

California pertussis epidemic, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Clustered cases of Bordetella pertussis infection cause high levels of IgG antibodies against pertussis toxin in adolescents in Gaobeidian city, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalence of pertussis in China: need to improve vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Consistency of Bordetella pertussis vaccine seed strains and potency of whole-cell pertussis vaccine still in use in Poland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Rationale for pertussis booster vaccination throughout life in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Effect of vaccination on Bordetella pertussis strains, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

European Sero-Epidemiology Network: standardisation of the assay results for pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

The seroepidemiology of Bordetella pertussis infection in Western Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSPD%2FFTV050

21 January 2018

Identifiers

DOI

10.1093/FEMSPD/FTV050

1 reference

4 September 2017

1 reference

PubMed ID

26208655